Latest News

Rohan Khera, MD, assistant professor of medicine (cardiovascular medicine), weighs in on the importance of including Black women and other groups in clinical trials.

Yale School of Medicine's Akiko Iwasaki, PhD, and Erica Spatz, MD, MHS, weigh in on the declining rates of long COVID.

Welcome Incoming Cardiovascular Medicine Fellows!

A collaborative study led by Yale researchers reports the many gene expression changes that develop over the course of a neurodegenerative disorder called spinocerebellar ataxia type 1, shedding light on its progression.

The medication has the potential to markedly reduce the risk of heart attacks and other heart-related conditions among millions of Americans with obesity who have also been diagnosed with cardiovascular disease, a Yale study shows.

Harlan Krumholz, MD, SM, Harold H. Hines, Jr. Professor of Medicine (Cardiology), comments on the impact of cardiovascular health on aging.

Yuan Lu, ScD, assistant professor of medicine (cardiovascular medicine), comments on a study that shows Wegovy reduced the risk of heart attack and stroke in some patients.

Using a new computational method based on a causal inference framework, CINEMA-OT, the Yale team studied how individual immune cells react to combinations of cytokines, or small proteins released by cells that regulate inflammation. They discovered that certain cytokines have a synergistic effect, inducing unique gene activation programs compared to their individual effects. This cryptography of cytokine signals acts as a language, instructing immune cells.